BioCorRx Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-3.4M | $-5.1M | $-3.8M | $-4.4M | $-5.2M | $-3.5M | $-6.0M | $-6.6M |
| Depreciation & Amortization | $44.0K | $33.1K | $26.8K | $27.5K | $64.3K | $77.3K | $29.4K | $7.4K |
| Depreciation | $14.9K | $32.0K | $25.6K | $26.3K | $27.8K | $28.9K | $16.0K | $5.4K |
| Amortization | — | — | — | — | — | — | $12.0K | — |
| Stock-Based Compensation | $592.6K | $1.2M | $277.1K | $354.5K | $209.5K | $355.0K | $2.0M | $2.8M |
| Net Cash from Operating Activities | $-2.3M | $-1.1M | $-1.9M | $-2.0M | $-3.5M | $-2.2M | $-2.9M | $-1.8M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | $0 | $2.0K | $0 | $-122.6K | $10.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | $0 | $-50.0K | $-9.2K | $-121.8K | $-55.9K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $2.3M | $1.1M | $1.8M | $2.0M | $3.1M | $107.3K | $5.4M | $2.2M |
| Net Change in Cash | — | — | — | — | $-506.2K | $-2.1M | $2.4M | $268.4K |
| Free Cash Flow | — | — | — | $-2.0M | $-3.5M | $-2.2M | $-2.8M | $-1.8M |